Abstract
Migration inhibitory factor (MIF) is associated with multiple organ dysfunction syndrome (MODS) in patients with systemic inflammatory response syndrome (SIRS). Our purposes were to determine the serum MIF, cortisol, and tumor narcosis factor-α (TNF-α) and to investigate the influences of the balance between the levels of MIF and cortisol in patients with blunt trauma. The cortisol levels were identical between the patients with and without MODS. However, the MIF and TNF-α levels in the patients with MODS were statistically higher than those of the patients without MODS. The cortisol/MIF ratios in the patients with MODS were statistically higher than those of the patients without MODS. The results show that MIF and TNF-α play an important role together in posttraumatic inflammatory response. An excessive serum MIF elevation overrides the anti-inflammatory effects of cortisol and leads to persistent SIRS followed by MODS in blunt trauma patients.
Similar content being viewed by others
References
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. 1992. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Critical Care Medicine 20: 864–874.
Malone, D.L., D. Kuhls, L.M. Napolitano, R. McCarter, and T. Scalea. 2001. Back to basics: Validation of the admission systemic inflammatory response syndrome score in predicting outcome in trauma. Journal of Trauma 51: 458–463.
Nast-Kolb, D., M. Aufmkolk, S. Rucholtz, U. Obertacke, and C. Waydhas. 2001. Multiple organ failure still a major cause of morbidity but not mortality in blunt multiple trauma. Journal of Trauma 51: 835–841.
Napolitano, L.M., T. Ferrer, R.J. McCarter Jr., and T.M. Scalea. 2000. Systemic inflammatory response syndrome score at admission independently predicts mortality and length of stay in trauma patients. Journal of Trauma 49: 647–652.
Bochicchio, G.V., L.M. Napolitano, M. Joshi, R.J. McCarter Jr., and T.M. Scalea. 2001. Systemic inflammatory response syndrome score at admission independently predicts infection in blunt trauma patients. Journal of Trauma 50: 817–820.
Rhen, T., and J.A. Cidlowski. 2005. Antiinflammatory action of glucocorticoids—New mechanisms for old drugs. New England Journal of Medicine 353: 1711–1723.
Baue, A.E. 2006. MOF, MODS, and SIRS: What is in a name or an acronym? Shock 26: 438–449.
Bloom, B.R., and B. Bennett. 1966. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity. Science 153: 80–82.
Calandra, T., J. Bernhagen, C.N. Metz, L.A. Spiegel, M. Bacher, T. Donnelly, A. Cerami, and R. Bucala. 1995. MIF as a glucocorticoid-induced modulator of cytokine production. Nature 377: 68–71.
Flaster, H., J. Bernhagen, T. Calandra, and R. Bucala. 2007. The macrophage migration inhibitory factor-glucocorticoid dyad: regulation of inflammation and immunity. Molecular Endocrinology 21: 1267–1280.
Gando, S., J. Nishihira, S. Kobayashi, Y. Morimoto, S. Nanzaki, and O. Kemmotsu. 2001. Macrophage migration inhibitory factor is a critical mediator of systemic inflammatory response syndrome. Intensive Care Medicine 27: 1187–1193.
Gando, S., A. Sawamura, M. Hayakawa, H. Hoshino, N. Kubota, and J. Nishihira. 2007. High macrophage migration inhibitory factor levels in disseminated intravascular coagulation patients with systemic inflammation. Inflammation 30: 118–124.
Chuang, C.C., C.J. Hung, M.C. Tsai, T.M. Yeh, and Y.C. Chuang. 2004. High concentrations of circulating macrophage migration inhibitory factor in patients with severe blunt trauma: Is serum macrophage migration inhibitory factor concentration a valuable prognostic factor? Critical Care Medicine 32: 734–739.
Baker, S.P., B. O'Neill, W. Haddon Jr., and W.B. Long. 1974. The injury severity score: A method for describing patients with multiple injuries and evaluating emergency care. Journal of Trauma 14: 187–196.
Vincent, J.L., A. de Mendonca, F. Cantraine, R. Moreno, J. Takala, P.M. Suter, C.L. Sprung, F. Colardyn, and S. Blecher. 1998. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: Results of a multicenter, prospective study. Working group on “sepsis-related problems” of the European Society of Intensive Care Medicine. Critical Care Medicine 26: 1793–1800.
Knaus, W.A., E.A. Draper, D.P. Wagner, and J.E. Zimmerman. 1985. APACHE II: A severity of disease classification system. Critical Care Medicine 13: 818–829.
Nishihira, J., Y. Koyama, and Y. Mizue. 1998. Identification of macrophage migration inhibitory factor (MIF) in human vascular endothelial cells and its induction by lipopolysaccharide. Cytokine 10: 199–205.
Strieter, R.M., S.L. Kunkel, and R.C. Bone. 1993. Role of tumor necrosis factor-alpha in disease states and inflammation. Critical Care Medicine 21: S447–S463.
Ozturk, H., Y. Yagmur, and H. Ozturk. 2008. The prognostic importance of serum IL-1beta, IL-6, IL-8 and TNF-alpha levels compared to trauma scoring systems for early mortality in children with blunt trauma. Pediatric Surgery International 24: 235–239.
Zedler, S., and E. Faist. 2006. The impact of endogenous triggers on trauma-associated inflammation. Current Opinion in Critical Care 12: 595–601.
Calandra, T., and R. Bucala. 1997. Macrophage migration inhibitory factor (MIF): A glucocorticoid counter-regulator within the immune system. Critical Reviews in Immunology 17: 77–88.
Calandra, T., J. Bernhagen, R.A. Mitchell, and R. Bucala. 1994. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor. Journal of Experimental Medicine 179: 1895–1902.
Bernhagen, J., R.A. Mitchell, T. Calandra, W. Voelter, A. Cerami, and R. Bucala. 1994. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF). Biochemistry 33: 14144–14155.
Calandra, T., B. Echtenacher, D.L. Roy, J. Pugin, C.N. Metz, L. Hultner, D. Heumann, D. Mannel, R. Bucala, and M.P. Glauser. 2000. Protection from septic shock by neutralization of macrophage migration inhibitory factor. Nature Medicine 6: 164–170.
Bacher, M., A. Meinhardt, H.Y. Lan, W. Mu, C.N. Metz, J.A. Chesney, T. Calandra, D. Gemsa, T. Donnelly, R.C. Atkins, and R. Bucala. 1997. Migration inhibitory factor expression in experimentally induced endotoxemia. American Journal of Pathology 150: 235–246.
Emonts, M., F.C. Sweep, N. Grebenchtchikov, A. Geurts-Moespot, M. Knaup, A.L. Chanson, V. Erard, P. Renner, P.W. Hermans, J.A. Hazelzet, and T. Calandra. 2007. Association between high levels of blood macrophage migration inhibitory factor, inappropriate adrenal response, and early death in patients with severe sepsis. Clinical Infectious Diseases 44: 1321–1328.
Author information
Authors and Affiliations
Corresponding author
Additional information
There was no financial support for this study.
Rights and permissions
About this article
Cite this article
Hayakawa, M., Katabami, K., Wada, T. et al. Imbalance Between Macrophage Migration Inhibitory Factor and Cortisol Induces Multiple Organ Dysfunction in Patients with Blunt Trauma. Inflammation 34, 193–197 (2011). https://doi.org/10.1007/s10753-010-9223-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-010-9223-2